Arbor Capital Management (Alaska)’s CME Group CME Stock Holding History

Arbor Capital Management (Alaska)’s Portfolio CME Stock Details CME Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.68M	Sell	5,665 -395	-7%	-$117K	1.37%	28
2025 Q4	$1.64M	Sell	6,060 -308	-5%	-$83.7K	1.38%	30
2025 Q3	$1.7M	Sell	6,368 -707	-10%	-$192K	1.37%	23
2025 Q2	$1.97M	Sell	7,075 -545	-7%	-$148K	1.72%	18
2025 Q1	$2.02M	Buy	7,620 +295	+4%	+$72.8K	1.96%	13
2024 Q4	$1.71M	Sell	7,325 -609	-8%	-$140K	1.68%	21
2024 Q3	$1.78M	Buy	7,934 +75	+1%	+$15.5K	1.68%	19
2024 Q2	$1.54M	Sell	7,859 -182	-2%	-$37.6K	1.41%	26
2024 Q1	$1.67M	Sell	8,041 -1,430	-15%	-$300K	1.58%	22
2023 Q4	$1.91M	Sell	9,471 -460	-5%	-$98.2K	1.43%	26
2023 Q3	$2.12M	Sell	9,931 -23	-0.2%	-$4.57K	1.89%	13
2023 Q2	$1.85M	Buy	9,954 +159	+2%	+$29.4K	1.43%	25
2023 Q1	$1.89M	Buy	9,795 +1,048	+12%	+$190K	1.53%	21
2022 Q4	$1.47M	Sell	8,747 -78	-0.9%	-$13.6K	1.3%	29
2022 Q3	$1.6M	Sell	8,825 -22	-0.2%	-$4.35K	1.44%	21
2022 Q2	$1.81M	Buy	8,847 +207	+2%	+$43.9K	1.73%	15
2022 Q1	$2.06M	Sell	8,640 -1,657	-16%	-$389K	1.58%	18
2021 Q4	$2.35M	Buy	+10,297	New	+$2.27M	1.67%	14

Other funds holding CME

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Arbor Capital Management (Alaska)'s CME Position: Q1 2026 in Review

Arbor Capital Management (Alaska) reduced its CME Group (CME) stake by 6.5% in Q1 2026, selling an estimated $117K and leaving 5,665 shares worth $1.68M. The position accounts for 1.37% of the portfolio, ranked #28.

Arbor Capital Management (Alaska) first reported a position in CME in Q4 2021 and has held it in 18 quarters since. The position peaked at $2.35M in Q4 2021. 1,791 funds tracked by Wall St. Rank hold CME as of Q1 2026.

Arbor Capital Management (Alaska) held 5,665 shares of CME Group worth $1.68M as of Q1 2026.
Arbor Capital Management (Alaska) sold 395 CME Group shares in Q1 2026, an estimated $117K.
CME Group made up 1.37% of Arbor Capital Management (Alaska)'s portfolio in Q1 2026, its #28 holding.
Arbor Capital Management (Alaska) first reported a position in CME Group in Q4 2021 and has held it in 18 quarters since.
Arbor Capital Management (Alaska)'s CME Group position peaked at $2.35M in Q4 2021.
1,791 funds tracked by Wall St. Rank held CME Group as of Q1 2026.

Based on Arbor Capital Management (Alaska)'s 13F filing for Q1 2026, filed 30 Apr 2026.